tiprankstipranks
Trending News
More News >
Crispr Therapeutics (CRSP)
:CRSP
US Market

Crispr Therapeutics AG (CRSP) Cash flow

Compare
10,666 Followers

Crispr Therapeutics AG Cash Flow

CRSP's free cash flow for Q3 2025 was $-84.71M. For the 2025 fiscal year, CRSP's free cash flow was decreased by $125.17M and operating cash flow was $-84.63M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -142.77M$ -260.38M$ -495.74M$ 538.97M$ -238.37M
Investing Cash Flow
$ -280.48M$ 374.65M$ -258.65M$ -1.04B$ -541.17M
Financing Cash Flow
$ 331.98M$ 62.66M$ 38.59M$ 250.94M$ 1.02B
End Cash Position
$ 309.78M$ 389.48M$ 224.06M$ 939.94M$ 1.19B
Free Cash Flow
$ -144.68M$ -269.85M$ -532.93M$ 457.27M$ -256.72M
Currency in USD

Crispr Therapeutics AG Cash Flow